Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Immunoprecise Antibodies Ltd IPA

ImmunoPrecise Antibodies Ltd. is a biotechnology company that leverages multi-omics modeling and complex artificial intelligence through a series of proprietary and patented technologies. The Company owns an integrated end-to-end suite of capabilities to support the development of therapeutic antibodies. It has several subsidiaries in North America and Europe including entities, such as Talem... see more

NDAQ:IPA - Post Discussion

View:
Post by wallpaper2 on Aug 04, 2021 2:20pm

Remember.

19.8 million shares out there in circulation is ridiculously miniscule. Avg, Nasdaq stock has 200 million shares outstanding, some have 500 million o/s. 
This could close today at $8.00....open tomorrow at $18.00....and close tomorrow at $48.00.
Likely to continue up on several strong news releases. The majority of the shares are in strong hands. They know what they own and they aren't losing any sleep over the day to day swings.
There are hundreds of Fund managers out there and I see where one NewYork fund named "Ingalls&Snyder"  added 85,000 shares recently and now own 600,000 shares of IPA.
That is just ONE fund. Try to wrap your head around what IPA's potential is. When people say this could explode, they aren't lying or pumping!!
Comment by Hollycrap on Aug 09, 2021 11:51am
I agree Wallpaper2 I have been following some of the bigger shareholders and there are the nice names behind this company who are looking either for human trials or the rumour of a takeout by big pharma which could be back at the $25 to $30 a share price which is still a bargin for big pharma give low float.
Comment by wallpaper2 on Aug 09, 2021 1:08pm
Big Pharma would have to be village idiots not to pay at least $25-$30 a share for IPA,  It will be worth 10X that next year.  Jennifer and her new appointments know what they have and what it is worth.  It's not their first rodeo, that is why she brought them on board to help her. They have taken companies to buyout before. I would be surprised to see them accept anything in ...more  
Comment by wallpaper2 on Aug 09, 2021 1:32pm
Hollycrap...did you choose your name based on the Dragon Den product by any chance?  I had them a listing in place and a shady ethnic group scared the US buyers away the day before they were scheduled to land in Vancouver to sign.
Comment by Hollycrap on Sep 01, 2021 12:11pm
Lol no 
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities